Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial

Ranee Chatterjee, Laine Thomas, Laura Svetkey, Frederick L. Brancati, Robert M. Califf, David Edelman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences